




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Mechanical Circulatory Support</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=6047010c-a7d7-4ea0-a54b-aafdfdfb8d01</link>
        <description>Clinical Topic Feed: Mechanical Circulatory Support</description>
        <language>en</language>

        

                <item>
                    <title>JACC State-of-the-Art Review Highlights Growing Need For dLVAD-Related Emergency Response Resources</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/03/12/18/40/JACC-State-of-the-Art</link>                    <description>With the population of stage D heart failure (HF) patients supported with durable left ventricular assist devices (dLVAD) rapidly expanding, a State-of-the-Art Review published in JACC provides a comprehensive overview of support and management of dLVAD-related emergencies, with an intent to provide a rapid-response guide for clinicians who encounter emergencies in patients with dLVADs.</description>
                    <pubdate>1773343260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Focus on Heart Failure | Clinical Considerations to Unlock the Potential of LVAD Therapy</title>
<link>/Latest-in-Cardiology/Articles/2025/11/01/01/Focus-on-Heart-Failure</link>                    <description>For select patients with advanced heart failure (AHF), durable left ventricular assist device (LVAD) therapy can be a life-sustaining option that improves quality of life. Since its introduction a few decades ago, the technology and associated clinical outcomes have evolved in a transformational manner.</description>
                    <pubdate>1761999180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Research at ASE 2025: AI in Echocardiography, Baseline LV Health and Early TAVR, More</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/09/18/19/00/Research-at-ASE-2025</link>                    <description>Research exploring the use of artificial intelligence (AI) in automating echocardiographic measurements, the impact of baseline left ventricular (LV) health on the benefit of early TAVR, and aortic regurgitation (AR) following use of percutaneous transaortic LV assist devices (pLAVD) was presented at ASE 2025 from Sept. 5-7 and simultaneously published in JACC and JACC: Cardiovascular Interventions.</description>
                    <pubdate>1758225780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Cannabis Use Increases Risk of MI, Evolut Low Risk, Altshock-2, SCA in Athletes</title>
<link>/Latest-in-Cardiology/Articles/2025/05/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1746101520000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Study on Early Intra-Aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic Shock</title>
<link>/Latest-in-Cardiology/Clinical-Trials/2025/03/28/02/34/altshock-2</link>                    <description>The goal of the Altshock-2 trial was to evaluate the effect of early intra-aortic balloon pump (IABP) use vs. standard care on 60-day survival or successful bridging to heart replacement therapies (HRT) in patients with heart failure&#226;€“cardiogenic shock (HF-CS).</description>
                    <pubdate>1743134400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New in Clinical Guidance | Newest AUC Provide Clinical Guidance on Cardiac Implantable Electronic Devices</title>
<link>/Latest-in-Cardiology/Articles/2025/02/01/42/New-in-Clinical-Guidance-Newest-AUC-Provide-Clinical-Guidance-on-Cardiac-Implantable-Electronic-Devices</link>                    <description>A new multi-society Appropriate Use Criteria (AUC) document focuses on cardiac implantable electronic devices (CIEDs), specifically implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) and pacing.</description>
                    <pubdate>1738415640000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Impact of Kinlessness on Older Adults With Advanced HF: Key Points</title>
<link>/Latest-in-Cardiology/ten-points-to-remember/2024/12/04/15/13/the-impact-of-kinlessness</link>                    <description>The following are key points to remember from a review about the negative impact kinlessness can have on older adults with advanced heart failure (HF) and potential solutions to the disparity of care.</description>
                    <pubdate>1733339040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Triage of Ambulatory Patients With Advanced HF</title>
<link>/Latest-in-Cardiology/Journal-Scans/2024/07/09/14/16/optimizing-triage-of-ambulatory</link>                    <description>What are 2-year clinical outcomes for ambulatory patients with advanced systolic heart failure (HF) on maximally tolerated evidence-based therapies?</description>
                    <pubdate>1720549800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FDA Update: Abbott Medical Issues Correction For HeartMate LVAS Monitor</title>
<link>/Latest-in-Cardiology/Articles/2024/07/01/19/54/fda-update-abbott-medical-issues-correction-for-heartmate-lvas-monitor</link>                    <description>The U.S. Food and Drug Administration (FDA) announced on June 28 that Abbott Medical has issued a correction for the HeartMate Left Ventricular Assist System (LVAS) Monitor due to screen issues that may cause unintentional pump stop.</description>
                    <pubdate>1719863760000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FDA Update: Abbott Recalls HeartMate 3 LVAS Implant Kit</title>
<link>/Latest-in-Cardiology/Articles/2024/05/20/13/57/fda-update-abbott-recalls-heartmate-3-lvas-implant-kit</link>                    <description>The U.S. Food and Drug Administration (FDA) announced on May 15 that Abbott is recalling the HeartMate 3 Left Ventricular Assist System (LVAS) implant kit due to risk of blood leakage or air entering the seal interface between the left ventricular assist device inflow cannula and the apical cuff.</description>
                    <pubdate>1715867940000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>